Healthcare -
Biotechnology - NASDAQ - BM
$ 18.54
0.816 %
$ 1.34 B
Market Cap
-154.5
P/E
KNSA - COST OF REVENUE
Cost of Revenue KNSA - Kiniksa Pharmaceuticals, Ltd.
56.5 M
LAST VALUE
149.23%
2 YEAR CAGR
187.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR